Although there were fewer CRT- and HSP70 or HSP90-positive cells in the CM-EE treatment group than in the doxorubicin treatment group, the possibility that CM-EE could induce ICD in breast cancer cells remained. The gene discussed is CALR; the disease is breast carcinoma.